1 to 7 of 7 Results
Plain Text - 356 B -
MD5: e7ee8f67aac4f997bd3e7904971511d9
Documentation |
R Data - 7.9 MB -
MD5: a9b4eed9e761fa17a576384d85675bc1
|
R Syntax - 1.3 KB -
MD5: 8838947b9868ab1e0fda1491b07d7eb7
|
Oct 28, 2016
Rème, Thierry; Emde, Martina; Seckinger, Anja; Hose, Dirk, 2016, "HDAMM-predictor: prediction of progression in asymptomatic myeloma patients", https://doi.org/10.11588/data/10092, heiDATA, V1
The HDAMM-predictor is based on microarray gene expression and predicts the risk of progression from asymptomatic to symptomatic myeloma. It divides the patients in three groups, from low to high risk to progress. It was generated according to the method published by Rème et al.... |
Gzip Archive - 4.3 MB -
MD5: 1182fbeba7bc1880b60c135f4c45058a
|
Adobe PDF - 128.9 KB -
MD5: 4864973f006f3acc7088b8595d3bc849
Documentation |
Adobe PDF - 592.9 KB -
MD5: d344f6608c8f75542ac1e55b4a396ed0
|